This is how much money Pfizer will earn from selling the vaccine

Pfizer expects to earn about $15 billion in its vaccine against Covid-19 this year, the company said on Tuesday. Pfizer's projection for profits from vaccines in 2021 mainly includes doses expected to be handed over under existing contracts, but new contracts are still expected, so revenues can also be [...]
Pfizer expects to earn about $15 billion in its vaccine against Covid-19 this year, the company said on Tuesday.
Pfizer's projection for profits from vaccines in 2021 mainly includes doses expected to be handed over under existing contracts, but new contracts are still expected, so revenue can be even bigger.
Pfizer also said he has sent 65 million doses so far, including 29 million in the United States.
The company said it could potentially do a total of 2 billion doses worldwide by the end of 2021, though it is not sure whether to sell all those doses.
Pfizer is the first vaccine to be approved for emergency use in the United Kingdom and the United States.











